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Low-Field vs. High-Field Proton MRS of Mouse Brain In
Vivo
In a recent paper on in vivo proton MRS of mouse brain at
9.4 T, Tka´cˇ et al. (1) reported high-quality single-voxel
spectra of small volumes, but failed to accomplish a fair
comparison with a previous study by Schwarcz et al. (2) at
2.35 T. Instead, the reader was left with the impression
that proton MRS of mouse brain at low field strengths is of
low value and is generally hampered by problems that are
either absent or avoidable at 9.4 T.
Although comparisons of MRI or MRS at different field
strengths are usually confounded by a variety of other
factors involving differences in radiofrequency coils, ac-
quisition techniques, and postprocessing procedures,
physiologic or biochemical quantities (such as metabolite
concentrations) should of course be independent mea-
sures. Tka´cˇ et al. (1) obtained total creatine (tCr) concen-
trations in mouse brain in vivo that were “in excellent
agreement with the published values” reported by
Schwarcz et al. (2). On the other hand, Schwarcz et al. (2)
obtained strong interstrain variabilities, whereas Tka´cˇ et
al. (1) found only small (though significant) metabolite
differences in the strains investigated. Assuming that the
low-field study was incorrect, Tka´cˇ et al. (1) offered a list
of problems that may explain this discrepancy. In partic-
ular, they noted that “the shimming resulted in threefold
broader line widths (in ppm) at 2.35 T” and that line
widths decreased rather than increased post mortem. They
further questioned a high in vivo concentration of glucose
(Glc), a nonzero post mortem concentration of Glc, and
complained about missing information about taurine
(Tau). They concluded that these flaws all “[point] to sys-
tematic errors in quantification” in the work of Schwarcz
et al. (2). The discrepancies between the two studies can be
described as follows:
1) Strain differences. Tka´cˇ et al. (1) compared C57BL/6
mice with CBA and CBA/BL6 mice and found interstrain
differences that were “limited to Gln, Glu, Ins, Lac, NAAG,
and PE,” whereas Schwarcz et al. (2) observed “substan-
tially larger differences in metabolite concentrations be-
tween other mouse strains”—more precisely between
C57BL/6 mice and BALB/c (tNAA, tCr, Cho, Glc, and Lac),
but not NMRI mice (except for Glc). In other words, each
study compared C57BL/6 mice with different strains and
reported variable interstrain dependencies. Thus, in con-
trast to what was suggested by Tka´cˇ et al. (1), both studies
were consistent with each other and did not report con-
flicting results.
2) Spectral resolution. When given in units of Hz rather
than in ppm, the line width allows for a direct comparison
with the coupling constants of multiplet resonances,
which for protons are on the order of 3–7 Hz. In fact,
despite a better relative resolution at 9.4 T that facilitates
the separation of glutamate and glutamine methylene mul-
tiplets, a full width at half maximum (FWHM) of 11–14 Hz
(1) is worse than the 6.9–9.3 Hz reported for 2.35 T (2), and
is not sufficient to unambiguously distinguish between
lactate (Lac) and lipids.
3) Post mortem line width. Tka´cˇ et al. (1) incorrectly
stated that Schwarcz et al. (2) observed a decrease of the
line width in C57BL/6 mice post mortem. In fact, the
FWHM remained unchanged in C57BL/6 and BALB/c
mice, and significantly increased for NMRI mice (see Table
2 in Ref. 2).
4) Glucose assignment. Although Tka´cˇ et al. (1) did not
identify Glc resonances in their spectra while they left no
resonances unassigned (see Fig. 1 of Ref. 1), they reported
Glc concentrations of 3–4 mol/g for different brain re-
gions in C57BL/6 mice. In contrast, low-field spectra con-
centrate most of the intensity of the Glc protons in a
well-defined apparent singlet at 3.43 ppm, which may be
readily exploited for accurate quantification by LCModel.
Moreover, whereas Schwarcz et al. (2) confirmed the Glc
assignment and quantification by its rapid decrease post
mortem (see Fig. 3 and Table 2 in Ref. 2), Tka´cˇ et al. (1) did
not perform such consistency experiments.
5) Glucose concentrations. Using a correction for CSF
partial volumes, Schwarcz et al. (2) reported Glc concen-
trations of 6.2  2.3 and 5.4  2.7 mM for anesthetized
NMRI and BALB/c mice, respectively, and 9.8  3.9 mM
for C57BL/6 mice. This latter value was characterized as
abnormally high and was suggested to reflect a strain-
related shift of the cerebral energy metabolism toward
enhanced anerobic glycolysis and/or alterations of glucose
transport. This understanding is in line with the well-
known vulnerability of the C57BL/6 strain to cerebral isch-
emia (see references in Ref. 2). It is also consistent with the
simultaneous observation of much higher Lac concentra-
tions in C57BL/6 mice (2.8 0.8 mM) than in NMRI (1.9
1.4 mM) and BALB/c mice (1.1  1.0 mM), while the
Glc/Lac ratio was found to be similar in all three strains
(2).
6) Lactate. In contrast to the results obtained at 2.35 T
(see previous section), Tka´cˇ et al. (1) reported in vivo Lac
concentrations of 4.5–6.5 mol/g in the striatum of differ-
ent strains. Such levels must be considered exceptionally
high under normal physiologic conditions. Apart from
putative difficulties with anesthesia, lipid suppression,
and spatial selectivity of the voxel, it may also be an
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indication of the limited power of LCModel to discrimi-
nate Lac and lipid resonances due to the unresolved Lac
doublet at 9.4 T.
7) Taurine. Without doubt there is a partial overlap of
Glc and Tau resonances in proton spectra at 2.35 T. Nev-
ertheless, it is still possible to quantify Tau by LCModel,
particularly if the Tau concentrations are assumed to be as
high as 8–13 mol/g (1). Although not explicitly stated,
Schwarcz et al. (2) indeed used a set of 12 metabolite
model spectra that included Tau. In line with a 7.0 T study
(3), the analysis yielded Tau concentrations of 6.7  3.1,
6.9  1.6, and 6.0  2.3 mM for NMRI, BALB/c, and
C57BL/6 mice, respectively. Their Cramer-Rao lower
bounds (20–35%) correspond with those for multiple me-
tabolites reported by Tka´cˇ et al. (1).
In summary, it must be concluded that the concentra-
tions of major metabolites in the mouse brain in vivo
reported at 9.4 T (1) and 2.35 T (2) are in general agree-
ment, and that both studies observed variations for two
different sets of strains. On the other hand, an unjustified
assignment of differences in the Glc and Tau concentra-
tions of C57BL/6 mice to apparent limitations of low-field
MRS must be rebutted. In fact, the use of high field
strengths introduces new problems, such as those caused
by the pronounced splitting of strongly spin-coupled res-
onances and the unavoidable broadening of resonance line
widths (in Hz). High fields in conjunction with advanced
shim capabilities certainly have their merits, as demon-
strated by Tka´cˇ et al. (1) using resolution-enhanced proton
MRS of the mouse brain in vivo. Nevertheless, it should be
good scientific practice to provide fair comparisons.
Thomas Michaelis*
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Biomedizinische NMR Forschungs GmbH am
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